Literature DB >> 8549478

Basic mechanisms of asthma.

H A Boushey1, J V Fahy.   

Abstract

Results of studies of the epidemiology, physiology, histopathology, and cell biology of asthma have revised our conception of the disease. Epidemiologic studies have shown asthma to be an important cause of death, suffering, and economic hardship. Physiologic studies have shown that asthma is a chronic illness characterized by persistent bronchial hyperreactivity. Histopathologic studies have shown characteristic changes: epithelial damage, deposition of collagen beneath the basement membrane, eosinophilic and lymphocytic infiltration, and hypertrophy and hyperplasia of goblet cells, submucosal glands, and airway smooth muscle. Studies of the functions of cells in the airway mucosa suggest that asthma may be fundamentally mediated by a difference in the type of lymphocyte predominating in the airway mucosa but may also involve complex interactions among resident and migratory cells. Asthma may thus result from sensitization of a subpopulation of CD4+ lymphocytes, the Th2 subtype, in the airways. These lymphocytes produce a family of cytokines that favor IgE production and the growth and activation of mast cells and eosinophils, arming the airways with the mechanisms of response to subsequent reexposure to the allergen. This conceptual model has stimulated research along lines that will almost certainly lead to powerful new treatments, and it has already put current therapies in a new light, clarifying the role of antinflammatory agents, especially of inhaled corticosteroids. This conceptual model has some limitations: it ignores new evidence on the role of the mast cell in producing cytokines and depends on results of studies of the effects of inhalation of allergen, although most asthma exacerbations are provoked by viral respiratory infection. Preliminary studies suggest that viral infection and allergen inhalation may involve the activation of different pathways, with viral infection activating production of cytokines by airway epithelial cells. Similar study of the mechanisms activated by inhalation of air toxics may provide important clues as to how they might induce or exacerbate asthma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549478      PMCID: PMC1518922          DOI: 10.1289/ehp.95103s6229

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  43 in total

1.  Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness.

Authors:  B L Bradley; M Azzawi; M Jacobson; B Assoufi; J V Collins; A M Irani; L B Schwartz; S R Durham; P K Jeffery; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1991-10       Impact factor: 10.793

Review 2.  Anti-inflammatory actions of steroids: molecular mechanisms.

Authors:  P J Barnes; I Adcock
Journal:  Trends Pharmacol Sci       Date:  1993-12       Impact factor: 14.819

3.  The effects of ozone, nitrogen dioxide, and sulfur dioxide on the experimentally induced allergic respiratory disorder in guinea pigs. II. The effects of ozone on the absorption and the retention of antigen in the lung.

Authors:  Y Matsumura
Journal:  Am Rev Respir Dis       Date:  1970-09

4.  Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.

Authors:  P Bradding; J A Roberts; K M Britten; S Montefort; R Djukanovic; R Mueller; C H Heusser; P H Howarth; S T Holgate
Journal:  Am J Respir Cell Mol Biol       Date:  1994-05       Impact factor: 6.914

5.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

6.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.

Authors:  J B Richman-Eisenstat; P G Jorens; C A Hébert; I Ueki; J A Nadel
Journal:  Am J Physiol       Date:  1993-04

7.  Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma.

Authors:  D Robinson; Q Hamid; A Bentley; S Ying; A B Kay; S R Durham
Journal:  J Allergy Clin Immunol       Date:  1993-08       Impact factor: 10.793

8.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.

Authors:  J V Fahy; K W Kim; J Liu; H A Boushey
Journal:  J Allergy Clin Immunol       Date:  1995-04       Impact factor: 10.793

9.  A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983.

Authors:  J W Yunginger; C E Reed; E J O'Connell; L J Melton; W M O'Fallon; M D Silverstein
Journal:  Am Rev Respir Dis       Date:  1992-10

Review 10.  Viruses as precipitants of asthma symptoms. I. Epidemiology.

Authors:  P K Pattemore; S L Johnston; P G Bardin
Journal:  Clin Exp Allergy       Date:  1992-03       Impact factor: 5.018

View more
  11 in total

Review 1.  Exosomes in immunoregulation of chronic lung diseases.

Authors:  K P Hough; D Chanda; S R Duncan; V J Thannickal; J S Deshane
Journal:  Allergy       Date:  2016-12-08       Impact factor: 13.146

2.  Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma.

Authors:  A Nakanishi; S Morita; H Iwashita; Y Sagiya; Y Ashida; H Shirafuji; Y Fujisawa; O Nishimura; M Fujino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 3.  Immunobiology of the critical asthma syndrome.

Authors:  Richart W Harper; Amir A Zeki
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

4.  Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice.

Authors:  Yanchun Li; Meng Sun; Huanji Cheng; Shanyu Li; Li Liu; Hongmei Qiao; Shucheng Hua; Jirong Lu
Journal:  Exp Mol Med       Date:  2011-04-30       Impact factor: 8.718

5.  Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.

Authors:  Jessy S Deshane; David T Redden; Meiqin Zeng; Marion L Spell; Jaroslaw W Zmijewski; John T Anderson; Rohit J Deshane; Amit Gaggar; Gene P Siegal; Edward Abraham; Mark T Dransfield; David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2014-10-25       Impact factor: 10.793

6.  Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation.

Authors:  D A Randolph; R Stephens; C J Carruthers; D D Chaplin
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

7.  Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation.

Authors:  Matthew E Poynter; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

8.  Severely blunted allergen-induced pulmonary Th2 cell response and lung hyperresponsiveness in type 1 transient receptor potential channel-deficient mice.

Authors:  Eda Yildirim; Michelle A Carey; Jeffrey W Card; Alexander Dietrich; Gordon P Flake; Yingpei Zhang; J Alyce Bradbury; Yvette Rebolloso; Dori R Germolec; Daniel L Morgan; Darryl C Zeldin; Lutz Birnbaumer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-13       Impact factor: 5.464

9.  Exposure to cigarette smoke impacts myeloid-derived regulatory cell function and exacerbates airway hyper-responsiveness.

Authors:  Yong Wang; Tong Huan Jin; Aisha Farhana; Jason Freeman; Kim Estell; Jaroslaw W Zmijewski; Amit Gaggar; Victor J Thannickal; Lisa M Schwiebert; Adrie J C Steyn; Jessy S Deshane
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

10.  Environmental air toxics: role in asthma occurrence?

Authors:  Gary L Larsen; Craig Beskid; Lata Shirnamé-Moré
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.